A Domain-Specific Role for NOTCH1 Signaling During Regeneration of the Adult Bone Marrow Endothelial Niche

Kostandin Pajcini,Lijian Shao,Kilian Sottoriva
DOI: https://doi.org/10.1016/j.exphem.2018.06.112
IF: 3.249
2018-01-01
Experimental Hematology
Abstract:Chemotherapy and radiotherapy are benchmark treatments for hematological disorders, but they come with multiple toxic side effects. We investigate a domain-specific role of the Notch1 receptor in the survival and regeneration of the endothelial bone marrow niche. The intracellular portion of the Notch1 receptor contains several distinct protein domains important for activation of target genes during mammalian development. The transcriptional activation domain (TAD) is the least conserved domain among the four mammalian Notch receptors. Using a transgenic knock-in mouse model, which lacks the TAD of the Notch1 receptor we show that heterozygous Notch1-delta-TAD (Notch1+/dTAD) mice develop to maturity, yet are severely limited in the ability to recover following challenge by chemotherapy or gamma irradiation. Within 9 days after chemotherapy, Notch1+/dTAD mice exhibit pancytopenia and severe weight loss. Deletion of a single Notch1 TAD allele promotes apoptosis and limits endothelial regeneration in the bone marrow microenvironment. This phenotype is unique to the loss of a single TAD, is not dependent on Notch1 allelic dose, and is verified by complete tissue-specific loss of endothelial Notch1. Presence of the delta-TAD allele interferes with the assembly of the Notch transcriptional complex on enhancers of target genes. We propose a TAD-dependent mechanism for modulation of Notch1 transcriptional activity, which is essential in tissues that require robust Notch signaling, such as early T-cell development and endothelial regeneration. Our studies reveal a signaling axis, downstream of Tie2 signaling, which functions during regeneration of the bone marrow endothelium and is crucial for hematopoietic recovery.
What problem does this paper attempt to address?